Olanzapine-induced delirium in a terminally ill cancer patient.
Morita
Tatsuya
T
Tei
You
Y
Shishido
Hideki
H
Inoue
Satoshi
S
D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use*; D003693:Delirium / Q000139:chemically induced*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology; D000077152:Olanzapine; D010166:Palliative Care / Q000379:methods; D013727:Terminal Care / Q000379:methods*
D000932:Antiemetics; D001569:Benzodiazepines; D000077152:Olanzapine